Summit Therapeutics Inc. (SMMT)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 4.9600 |
| Open | 5.0100 |
| Bid | 4.7600 x 1200 |
| Ask | 4.7900 x 1200 |
| Day's range | 4.6450 - 5.1582 |
| 52-week range | 1.5000 - 5.3900 |
| Volume | |
| Avg. volume | 2,281,482 |
| Market cap | 3.355B |
| Beta (5Y monthly) | -1.13 |
| PE ratio (TTM) | 12.58 |
| EPS (TTM) | 0.3800 |
| Earnings date | 07 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 6.50 |
Insider MonkeySummit Therapeutics Inc. (NASDAQ:SMMT) Q1 2024 Earnings Call Transcript
Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2024 Earnings Call Transcript May 1, 2024 Summit Therapeutics Inc. reports earnings inline with expectations. Reported EPS is $-0.06 EPS, expectations were $-0.06. SMMT isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies […]
- GuruFocus.com
Summit Therapeutics Inc (SMMT) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights ...
Explore key takeaways from Summit Therapeutics' Q1 2024 earnings, including robust financial positioning and pivotal clinical advancements.
- Thomson Reuters StreetEvents
Q1 2024 Summit Therapeutics Inc Earnings Call
Q1 2024 Summit Therapeutics Inc Earnings Call
© 2024 Yahoo. All rights reserved.